Development and Validation of a Novel Acute Myeloid Leukemia–Composite Model to Estimate Risks of Mortality

IMPORTANCE: To our knowledge, this multicenter analysis is the first to test and validate (1) the prognostic impact of comorbidities on 1-year mortality after initial therapy of acute myeloid leukemia (AML) and (2) a novel, risk-stratifying composite model incorporating comorbidities, age, and cytog...

Descripción completa

Detalles Bibliográficos
Autores principales: Sorror, Mohamed L., Storer, Barry E., Fathi, Amir T., Gerds, Aaron T., Medeiros, Bruno C., Shami, Paul, Brunner, Andrew M., Sekeres, Mikkael A., Mukherjee, Sudipto, Peña, Esteban, Elsawy, Mahmoud, Wardyn, Shylo, Whitten, Jennifer, Moore, Rachelle, Becker, Pamela S., McCune, Jeannine S., Appelbaum, Frederick R., Estey, Elihu H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2017
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5824273/
https://www.ncbi.nlm.nih.gov/pubmed/28880971
http://dx.doi.org/10.1001/jamaoncol.2017.2714

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5824273/
https://www.ncbi.nlm.nih.gov/pubmed/28880971
http://dx.doi.org/10.1001/jamaoncol.2017.2714

Ejemplares similares